Report Detail

Request for Sample of this report

Pharma & Healthcare Global Medicated Chewing Gums Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

  • RnM4653588
    • |
  • 05 December, 2025
    • |
  • Global
    • |
  • 144 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Medicated Chewing Gums market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Medicated Chewing Gums market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Medicated Chewing Gums market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Medicated Chewing Gums market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Medicated Chewing Gums market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Medicated Chewing Gums market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Medicated Chewing Gums
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Medicated Chewing Gums market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Rugby, Nicorette, Enorama, Skyepharma, FIA, Dimenhydrinate, Fertin Pharma, Skyepharma Production SAS, Alkalon, ENORAMA PHARMA AB, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Medicated Chewing Gums market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Solid
Semi-solid
Market segment by Application
Nursing Homes
Hospitals
Smoking Cessation Center
Home
Others
Major players covered
Rugby
Nicorette
Enorama
Skyepharma
FIA
Dimenhydrinate
Fertin Pharma
Skyepharma Production SAS
Alkalon
ENORAMA PHARMA AB
Mastix
Agro Gums
Perfetti Van Melle
WM
GlaxoSmithKline (GSK)
Mylan
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Medicated Chewing Gums product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Medicated Chewing Gums, with price, sales quantity, revenue, and global market share of Medicated Chewing Gums from 2020 to 2025.
Chapter 3, the Medicated Chewing Gums competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Medicated Chewing Gums breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Medicated Chewing Gums market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Medicated Chewing Gums.
Chapter 14 and 15, to describe Medicated Chewing Gums sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Medicated Chewing Gums Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Solid
    • 1.3.3 Semi-solid
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Medicated Chewing Gums Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Nursing Homes
    • 1.4.3 Hospitals
    • 1.4.4 Smoking Cessation Center
    • 1.4.5 Home
    • 1.4.6 Others
  • 1.5 Global Medicated Chewing Gums Market Size & Forecast
    • 1.5.1 Global Medicated Chewing Gums Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Medicated Chewing Gums Sales Quantity (2020-2031)
    • 1.5.3 Global Medicated Chewing Gums Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Rugby
    • 2.1.1 Rugby Details
    • 2.1.2 Rugby Major Business
    • 2.1.3 Rugby Medicated Chewing Gums Product and Services
    • 2.1.4 Rugby Medicated Chewing Gums Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Rugby Recent Developments/Updates
  • 2.2 Nicorette
    • 2.2.1 Nicorette Details
    • 2.2.2 Nicorette Major Business
    • 2.2.3 Nicorette Medicated Chewing Gums Product and Services
    • 2.2.4 Nicorette Medicated Chewing Gums Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Nicorette Recent Developments/Updates
  • 2.3 Enorama
    • 2.3.1 Enorama Details
    • 2.3.2 Enorama Major Business
    • 2.3.3 Enorama Medicated Chewing Gums Product and Services
    • 2.3.4 Enorama Medicated Chewing Gums Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Enorama Recent Developments/Updates
  • 2.4 Skyepharma
    • 2.4.1 Skyepharma Details
    • 2.4.2 Skyepharma Major Business
    • 2.4.3 Skyepharma Medicated Chewing Gums Product and Services
    • 2.4.4 Skyepharma Medicated Chewing Gums Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Skyepharma Recent Developments/Updates
  • 2.5 FIA
    • 2.5.1 FIA Details
    • 2.5.2 FIA Major Business
    • 2.5.3 FIA Medicated Chewing Gums Product and Services
    • 2.5.4 FIA Medicated Chewing Gums Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 FIA Recent Developments/Updates
  • 2.6 Dimenhydrinate
    • 2.6.1 Dimenhydrinate Details
    • 2.6.2 Dimenhydrinate Major Business
    • 2.6.3 Dimenhydrinate Medicated Chewing Gums Product and Services
    • 2.6.4 Dimenhydrinate Medicated Chewing Gums Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Dimenhydrinate Recent Developments/Updates
  • 2.7 Fertin Pharma
    • 2.7.1 Fertin Pharma Details
    • 2.7.2 Fertin Pharma Major Business
    • 2.7.3 Fertin Pharma Medicated Chewing Gums Product and Services
    • 2.7.4 Fertin Pharma Medicated Chewing Gums Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Fertin Pharma Recent Developments/Updates
  • 2.8 Skyepharma Production SAS
    • 2.8.1 Skyepharma Production SAS Details
    • 2.8.2 Skyepharma Production SAS Major Business
    • 2.8.3 Skyepharma Production SAS Medicated Chewing Gums Product and Services
    • 2.8.4 Skyepharma Production SAS Medicated Chewing Gums Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Skyepharma Production SAS Recent Developments/Updates
  • 2.9 Alkalon
    • 2.9.1 Alkalon Details
    • 2.9.2 Alkalon Major Business
    • 2.9.3 Alkalon Medicated Chewing Gums Product and Services
    • 2.9.4 Alkalon Medicated Chewing Gums Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Alkalon Recent Developments/Updates
  • 2.10 ENORAMA PHARMA AB
    • 2.10.1 ENORAMA PHARMA AB Details
    • 2.10.2 ENORAMA PHARMA AB Major Business
    • 2.10.3 ENORAMA PHARMA AB Medicated Chewing Gums Product and Services
    • 2.10.4 ENORAMA PHARMA AB Medicated Chewing Gums Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 ENORAMA PHARMA AB Recent Developments/Updates
  • 2.11 Mastix
    • 2.11.1 Mastix Details
    • 2.11.2 Mastix Major Business
    • 2.11.3 Mastix Medicated Chewing Gums Product and Services
    • 2.11.4 Mastix Medicated Chewing Gums Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Mastix Recent Developments/Updates
  • 2.12 Agro Gums
    • 2.12.1 Agro Gums Details
    • 2.12.2 Agro Gums Major Business
    • 2.12.3 Agro Gums Medicated Chewing Gums Product and Services
    • 2.12.4 Agro Gums Medicated Chewing Gums Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Agro Gums Recent Developments/Updates
  • 2.13 Perfetti Van Melle
    • 2.13.1 Perfetti Van Melle Details
    • 2.13.2 Perfetti Van Melle Major Business
    • 2.13.3 Perfetti Van Melle Medicated Chewing Gums Product and Services
    • 2.13.4 Perfetti Van Melle Medicated Chewing Gums Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Perfetti Van Melle Recent Developments/Updates
  • 2.14 WM
    • 2.14.1 WM Details
    • 2.14.2 WM Major Business
    • 2.14.3 WM Medicated Chewing Gums Product and Services
    • 2.14.4 WM Medicated Chewing Gums Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 WM Recent Developments/Updates
  • 2.15 GlaxoSmithKline (GSK)
    • 2.15.1 GlaxoSmithKline (GSK) Details
    • 2.15.2 GlaxoSmithKline (GSK) Major Business
    • 2.15.3 GlaxoSmithKline (GSK) Medicated Chewing Gums Product and Services
    • 2.15.4 GlaxoSmithKline (GSK) Medicated Chewing Gums Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 GlaxoSmithKline (GSK) Recent Developments/Updates
  • 2.16 Mylan
    • 2.16.1 Mylan Details
    • 2.16.2 Mylan Major Business
    • 2.16.3 Mylan Medicated Chewing Gums Product and Services
    • 2.16.4 Mylan Medicated Chewing Gums Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.16.5 Mylan Recent Developments/Updates

3 Competitive Environment: Medicated Chewing Gums by Manufacturer

  • 3.1 Global Medicated Chewing Gums Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Medicated Chewing Gums Revenue by Manufacturer (2020-2025)
  • 3.3 Global Medicated Chewing Gums Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Medicated Chewing Gums by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Medicated Chewing Gums Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Medicated Chewing Gums Manufacturer Market Share in 2024
  • 3.5 Medicated Chewing Gums Market: Overall Company Footprint Analysis
    • 3.5.1 Medicated Chewing Gums Market: Region Footprint
    • 3.5.2 Medicated Chewing Gums Market: Company Product Type Footprint
    • 3.5.3 Medicated Chewing Gums Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Medicated Chewing Gums Market Size by Region
    • 4.1.1 Global Medicated Chewing Gums Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Medicated Chewing Gums Consumption Value by Region (2020-2031)
    • 4.1.3 Global Medicated Chewing Gums Average Price by Region (2020-2031)
  • 4.2 North America Medicated Chewing Gums Consumption Value (2020-2031)
  • 4.3 Europe Medicated Chewing Gums Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Medicated Chewing Gums Consumption Value (2020-2031)
  • 4.5 South America Medicated Chewing Gums Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Medicated Chewing Gums Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Medicated Chewing Gums Sales Quantity by Type (2020-2031)
  • 5.2 Global Medicated Chewing Gums Consumption Value by Type (2020-2031)
  • 5.3 Global Medicated Chewing Gums Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Medicated Chewing Gums Sales Quantity by Application (2020-2031)
  • 6.2 Global Medicated Chewing Gums Consumption Value by Application (2020-2031)
  • 6.3 Global Medicated Chewing Gums Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Medicated Chewing Gums Sales Quantity by Type (2020-2031)
  • 7.2 North America Medicated Chewing Gums Sales Quantity by Application (2020-2031)
  • 7.3 North America Medicated Chewing Gums Market Size by Country
    • 7.3.1 North America Medicated Chewing Gums Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Medicated Chewing Gums Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Medicated Chewing Gums Sales Quantity by Type (2020-2031)
  • 8.2 Europe Medicated Chewing Gums Sales Quantity by Application (2020-2031)
  • 8.3 Europe Medicated Chewing Gums Market Size by Country
    • 8.3.1 Europe Medicated Chewing Gums Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Medicated Chewing Gums Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Medicated Chewing Gums Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Medicated Chewing Gums Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Medicated Chewing Gums Market Size by Region
    • 9.3.1 Asia-Pacific Medicated Chewing Gums Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Medicated Chewing Gums Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Medicated Chewing Gums Sales Quantity by Type (2020-2031)
  • 10.2 South America Medicated Chewing Gums Sales Quantity by Application (2020-2031)
  • 10.3 South America Medicated Chewing Gums Market Size by Country
    • 10.3.1 South America Medicated Chewing Gums Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Medicated Chewing Gums Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Medicated Chewing Gums Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Medicated Chewing Gums Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Medicated Chewing Gums Market Size by Country
    • 11.3.1 Middle East & Africa Medicated Chewing Gums Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Medicated Chewing Gums Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Medicated Chewing Gums Market Drivers
  • 12.2 Medicated Chewing Gums Market Restraints
  • 12.3 Medicated Chewing Gums Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Medicated Chewing Gums and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Medicated Chewing Gums
  • 13.3 Medicated Chewing Gums Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Medicated Chewing Gums Typical Distributors
  • 14.3 Medicated Chewing Gums Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Medicated Chewing Gums. Industry analysis & Market Report on Medicated Chewing Gums is a syndicated market report, published as Global Medicated Chewing Gums Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Medicated Chewing Gums market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo